Vision in Children Born to Opioid-dependent Methadone-maintained Mothers
VINCH
1 other identifier
observational
200
1 country
1
Brief Summary
The investigators will re-investigate 150 children studied extensively in the past. 100 of these children were born to mothers prescribed methadone during their pregnancy because of opiate dependency, and 50 were comparison children who were not exposed to drugs. These children were investigated when they were newborn babies, and again when they were six months old, and a quarter of the drug-exposed babies had problems with their eyesight, whilst very few of the comparison children has eyesight problems. The investigators would like to see whether the eyesight problems are still present in the children now that they are older. Because they are older, more detailed testing can be undertaken which will help to understand how drug exposure in the womb may have affected their eyesight. The investigators will recruit new, comparison children to the study to match the number of comparison children with the number of drug-exposed children. The findings will be relevant and important when advising mothers on drug use - both prescribed and illicit - when they are pregnant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedFirst Posted
Study publicly available on registry
July 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedAugust 1, 2018
July 1, 2018
1.6 years
March 22, 2017
July 30, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
presence of strabismus, nystagmus, reduced acuity, significant refractive error
natural history of visual abnormalities following in utero exposure to methadone +/- other drugs
2 years
Secondary Outcomes (1)
correlation of abnormality or normality with prenatal drug exposure
2 years
Eligibility Criteria
100 drug-exposed neonates and 50 comparison infants, all born between 13/08/2008 and 30/04/2009 at the Princess Royal Maternity in Glasgow, previously recruited to the VIDI study; an additional 50 classroom comparison children.
You may qualify if:
- cases: born to opioid-dependent mothers prescribed substitute methadone during pregnancy and delivered after 36 completed weeks' gestation.
- comparisons: healthy, non drug-exposed infants delivered within the same maternity unit, matched for gestation, birthweight ± 250g and Carstairs deprivation score ± 1; attempted match for smoking
You may not qualify if:
- congenital ocular abnormality; significant neonatal illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Waterloocollaborator
Study Sites (1)
Children's Clinical Research Facility (CRF), Queen Elizabeth University Hospital
Glasgow, G51 4TF, United Kingdom
Related Publications (1)
Hamilton R, Mulvihill A, Butler L, Chow A, Irving E, McCulloch DL, McNeil A, Michael K, Spowart KM, Waterson-Wilson J, Mactier H. Impaired vision in children prenatally exposed to methadone: an observational cohort study. Eye (Lond). 2024 Jan;38(1):118-126. doi: 10.1038/s41433-023-02644-3. Epub 2023 Jul 4.
PMID: 37402864DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ruth Hamilton, PhD
NHS Greater Glasgow & Clyde
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2017
First Posted
July 27, 2018
Study Start
July 1, 2017
Primary Completion
February 1, 2019
Study Completion
June 1, 2020
Last Updated
August 1, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share